|
|
|
|
LEADER |
03503nma a2201057 u 4500 |
001 |
EB002157943 |
003 |
EBX01000000000000001296058 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
230515 ||| eng |
020 |
|
|
|a 9783036567020
|
020 |
|
|
|a 9783036567037
|
020 |
|
|
|a books978-3-0365-6702-0
|
100 |
1 |
|
|a Nicoletta, Fiore P.
|
245 |
0 |
0 |
|a Nanomaterials for Drug Delivery and Cancer Therapy
|h Elektronische Ressource
|
260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
300 |
|
|
|a 1 electronic resource (236 p.)
|
653 |
|
|
|a prussian blue nanoparticles
|
653 |
|
|
|a theranostic
|
653 |
|
|
|a thermal therapy
|
653 |
|
|
|a TfR-overexpressed cancer cells
|
653 |
|
|
|a cystamine
|
653 |
|
|
|a dextran conjugate
|
653 |
|
|
|a mucosal immune response
|
653 |
|
|
|a fluorescent dyes
|
653 |
|
|
|a magnetic nanoparticles
|
653 |
|
|
|a H-aggregates
|
653 |
|
|
|a uptake routes
|
653 |
|
|
|a DNA vaccine
|
653 |
|
|
|a mRNA vaccine
|
653 |
|
|
|a gold nanoparticles
|
653 |
|
|
|a self-assembling nanoparticles
|
653 |
|
|
|a targeted release
|
653 |
|
|
|a fluorescent lifetime
|
653 |
|
|
|a n/a
|
653 |
|
|
|a intranasal delivery
|
653 |
|
|
|a brain cancer
|
653 |
|
|
|a pancreatic cancer
|
653 |
|
|
|a magnetic fluid hyperthermia
|
653 |
|
|
|a immunogenic cell death
|
653 |
|
|
|a siRNA delivery
|
653 |
|
|
|a History of engineering and technology / bicssc
|
653 |
|
|
|a hadron therapy
|
653 |
|
|
|a immunotherapy
|
653 |
|
|
|a hyaluronic acid
|
653 |
|
|
|a Technology: general issues / bicssc
|
653 |
|
|
|a glioblastoma
|
653 |
|
|
|a drug-siRNA co-delivery systems
|
653 |
|
|
|a polarization
|
653 |
|
|
|a indocyanine green
|
653 |
|
|
|a pH/redox responsive nanoparticles
|
653 |
|
|
|a radioenhancer
|
653 |
|
|
|a near-infrared range
|
653 |
|
|
|a carbon nanodots
|
653 |
|
|
|a phagocytosis
|
653 |
|
|
|a hyperthermia
|
653 |
|
|
|a nanomaterials
|
653 |
|
|
|a macrophages
|
653 |
|
|
|a outer membrane vesicles
|
653 |
|
|
|a cancer
|
653 |
|
|
|a cancer treatment
|
653 |
|
|
|a RNA nanotechnology
|
653 |
|
|
|a nanoparticles
|
653 |
|
|
|a pulmonary delivery
|
653 |
|
|
|a aFn14 antibody
|
653 |
|
|
|a seliciclib
|
653 |
|
|
|a PEG diacid
|
653 |
|
|
|a glioma C6
|
653 |
|
|
|a fluorescent diagnosis
|
653 |
|
|
|a multifunctional nanocarrier
|
653 |
|
|
|a nano-biosensor
|
653 |
|
|
|a folic acid
|
653 |
|
|
|a targeted therapy
|
653 |
|
|
|a drug delivery
|
653 |
|
|
|a photothermal therapy
|
653 |
|
|
|a drug targeting
|
653 |
|
|
|a T7 peptide
|
700 |
1 |
|
|a Iemma, Francesca
|
700 |
1 |
|
|a Nicoletta, Fiore P.
|
700 |
1 |
|
|a Iemma, Francesca
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
028 |
5 |
0 |
|a 10.3390/books978-3-0365-6702-0
|
856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/98049
|z DOAB: description of the publication
|
856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/6795
|7 0
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 900
|
082 |
0 |
|
|a 700
|
082 |
0 |
|
|a 600
|
082 |
0 |
|
|a 620
|
520 |
|
|
|a This reprint of "Nanomaterials for Drug Delivery and Cancer Therapy" covers the recent advances in the use of nanoparticle systems, with an emphasis on preparation and characterization methods, functionalization chemistry, and their associated applications in drug delivery and cancer therapy.
|